Dendrimers and dendritic polymers in drug delivery.
By E. Gillies, J. Fréchet. Drug Discovery Today, 2005
1,234 citations recorded by the source corpus.
Subfields: Molecular Biology, Polymers and Plastics
View Paper: https://www.semanticscholar.org/paper/75fa35e363e7dfba9af11ff19b1a4bd1d3e8f545
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Nicholas A. Peppas
- O. Farokhzad
- I. Uchegbu
- C. Dufès
- A. Schätzlein
- Ali Khademhosseini
- R. Duncan
- Allan S. Hoffman
In Polymers and Plastics
Citations in the corpus
- Dendrimers in gene delivery. (2005, background): “These hyper-branched molecules were called bdendrimersQ or barborolsQ (from the Latin barborQ also meaning tree, for a historical view see review [25–32]).”
- Polymer conjugates as anticancer nanomedicines (2006, background): “New polymeric carriers (including carriers of unique architecture”
- Nanocomposite hydrogels for biomedical applications (2013, background): “Due to their unique nanostructure, they display a multitude of functional groups on their periphery, resulting in higher reactivity and loading efficiency compared to the polymeric hydrogels fabricated from linear polymers (Gillies and Frechet, 2005).”
- Dendrimers: synthesis, applications, and properties (2014, background): “Furthermore, highly sensitive analytical devices [77,78], MRI contrast agents [79], prion research [80], burn treatment [81], and EPR imaging with spin-labeled dendrimers [82-106] are some of the diverse areas of fascinating ongoing dendrimer research that are beyond the scope of this article.”
- Nanocarriers as an emerging platform for cancer therapy. (2007, background): “This work provided motivation for further pre-clinical development, and a variety of dendrimers are now under investigation for cancer treatment and are extensively reviewed elsewher”